Dienogest is a selective luteinizing hormone drug that has been newly launched in recent years. It can stabilize endometrial tissue by specifically binding to ethylene nortestosterone and progesterone derivatives. Studies have found that tumor necrosis factor (TNF). and interleukin (IL-8) tend to increase in patients with endometriosis.